World's Best Scientists 2026 revealed!
Christopher Sweeney

Christopher Sweeney

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Medicine 93 10707 10054 5504 5087 581 42405

Christopher Sweeney publications per year

The chart shows the history of publications by Christopher Sweeney between 1993 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Christopher Sweeney published across 33 years, from 1993 to 2025, averaging 27.5 papers a year. Output peaked at 162 publications in 2023. 140 of the 908 publications appeared in the last two years.

No. of publications
50 100 150
Bar chart. Horizontal axis: year, 1993 to 2025. Vertical axis: number of publications, 0 to 162. Peak 162 publications in 2023. 1993: 1 publication 1994: 0 publications 1995: 0 publications 1996: 0 publications 1997: 0 publications 1998: 3 publications 1999: 2 publications 2000: 9 publications 2001: 9 publications 2002: 8 publications 2003: 8 publications 2004: 15 publications 2005: 11 publications 2006: 17 publications 2007: 16 publications 2008: 16 publications 2009: 8 publications 2010: 15 publications 2011: 21 publications 2012: 17 publications 2013: 25 publications 2014: 37 publications 2015: 66 publications 2016: 56 publications 2017: 61 publications 2018: 37 publications 2019: 52 publications 2020: 37 publications 2021: 34 publications 2022: 25 publications 2023: 162 publications 2024: 101 publications 2025: 39 publications
1993 2025

908 publications in total across all disciplines

View publications per year as a table
Christopher Sweeney: publications per year, 1993 to 2025
Year Publications
1993 1
1994 0
1995 0
1996 0
1997 0
1998 3
1999 2
2000 9
2001 9
2002 8
2003 8
2004 15
2005 11
2006 17
2007 16
2008 16
2009 8
2010 15
2011 21
2012 17
2013 25
2014 37
2015 66
2016 56
2017 61
2018 37
2019 52
2020 37
2021 34
2022 25
2023 162
2024 101
2025 39
Total 908
Download as CSV

Christopher Sweeney publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Christopher Sweeney sits on this spectrum.

No. of scientists
200 400 600 800
Bar chart with 86 bars. Horizontal axis: publications, 101–120 to 1,796+. Vertical axis: number of scientists, 0 to 922. Most scientists, 922, have 341–360 publications. The last bar groups every scientist with 1,796 publications or more. The highlighted bar, 581–600 publications, is where this scientist sits. 101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101–120 publications 1,796+

This scientist: 581 publications — 69th percentile

69% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

View publications distribution as a table
Number of Medicine scientists by publication count, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
Publications Scientists This scientist
101–120 5
121–140 26
141–160 73
161–180 155
181–200 230
201–220 363
221–240 487
241–260 545
261–280 722
281–300 768
301–320 834
321–340 895
341–360 922
361–380 838
381–400 861
401–420 918
421–440 806
441–460 771
461–480 751
481–500 713
501–520 617
521–540 610
541–560 537
561–580 504
581–600 509 581
601–620 396
621–640 386
641–660 371
661–680 340
681–700 336
701–720 307
721–740 259
741–760 230
761–780 228
781–800 217
801–820 204
821–840 186
841–860 177
861–880 155
881–900 139
901–920 145
921–940 116
941–960 133
961–980 91
981–1,000 96
1,001–1,020 77
1,021–1,040 70
1,041–1,060 63
1,061–1,080 77
1,081–1,100 49
1,101–1,120 54
1,121–1,140 49
1,141–1,160 51
1,161–1,180 35
1,181–1,200 39
1,201–1,220 26
1,221–1,240 37
1,241–1,260 36
1,261–1,280 27
1,281–1,300 32
1,301–1,320 28
1,321–1,340 17
1,341–1,360 30
1,361–1,380 28
1,381–1,400 17
1,401–1,420 21
1,421–1,440 15
1,441–1,460 12
1,461–1,480 12
1,481–1,500 18
1,501–1,520 14
1,521–1,540 17
1,541–1,560 15
1,561–1,580 6
1,581–1,600 2
1,601–1,620 12
1,621–1,640 11
1,641–1,660 8
1,661–1,680 5
1,681–1,700 5
1,701–1,720 10
1,721–1,740 12
1,741–1,760 14
1,761–1,780 6
1,781–1,795 5
1,796+ 100
Download as CSV

Christopher Sweeney D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Christopher Sweeney sits on this spectrum.

No. of scientists
250 500 750 1,000
Bar chart with 75 bars. Horizontal axis: D-Index, 70–71 to 217+. Vertical axis: number of scientists, 0 to 1,027. Most scientists, 1,027, have 82–83 D-Index. The last bar groups every scientist with 217 D-Index or more. The highlighted bar, 92–93 D-Index, is where this scientist sits. 70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70–71 D-Index 217+

This scientist: 93 D-Index — 47th percentile

47% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

View D-Index distribution as a table
Number of Medicine scientists by D-index, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
D-Index Scientists This scientist
70–71 226
72–73 391
74–75 574
76–77 730
78–79 891
80–81 972
82–83 1,027
84–85 1,003
86–87 960
88–89 970
90–91 922
92–93 839 93
94–95 808
96–97 779
98–99 668
100–101 611
102–103 630
104–105 513
106–107 541
108–109 445
110–111 429
112–113 399
114–115 393
116–117 318
118–119 302
120–121 287
122–123 255
124–125 256
126–127 252
128–129 230
130–131 179
132–133 168
134–135 163
136–137 159
138–139 134
140–141 134
142–143 118
144–145 109
146–147 106
148–149 74
150–151 79
152–153 80
154–155 87
156–157 57
158–159 74
160–161 69
162–163 60
164–165 53
166–167 39
168–169 42
170–171 32
172–173 39
174–175 40
176–177 28
178–179 19
180–181 23
182–183 31
184–185 18
186–187 20
188–189 22
190–191 13
192–193 21
194–195 12
196–197 12
198–199 14
200–201 15
202–203 13
204–205 10
206–207 8
208–209 4
210–211 12
212–213 11
214–215 10
216 4
217+ 98
Download as CSV

Overview

Christopher Sweeney is affiliated with Harvard University in the United States and has made significant contributions to the field of medicine, particularly focusing on prostate cancer research and treatment. Their work spans multiple disciplines, including biochemistry, genetics, and molecular biology.

Sweeney's research covers a range of subfields, with substantial publications in pulmonary and respiratory medicine, cancer research, oncology, radiology, nuclear medicine and imaging, and molecular biology. Their main research topics include prostate cancer treatment and research, prostate cancer diagnosis and treatment, cancer lipids and metabolism, radiopharmaceutical chemistry and applications, cancer immunotherapy and biomarkers, cancer genomics and diagnostics, and testicular diseases and treatments.

The scientist has published extensively in several prominent journals. The most frequent venues include:

  • Journal of Clinical Oncology (51 publications)
  • Annals of Oncology (18 publications)
  • European Urology (16 publications)
  • European Urology Oncology (7 publications)
  • European Journal of Cancer (6 publications)

Key recent papers by Christopher Sweeney demonstrate a focus on advanced cancer therapies and clinical trials. Some of these include:

  • "Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019" (2020, European Urology)
  • "Pertuzumab and trastuzumab for HER2-positive, metastatic biliary tract cancer (MyPathway): a multicentre, open-label, phase 2a, multiple basket study" (2021, The Lancet Oncology)
  • "Ipatasertib plus abiraterone and prednisolone in metastatic castration-resistant prostate cancer (IPATential150): a multicentre, randomised, double-blind, phase 3 trial" (2021, The Lancet)
  • "Atezolizumab with enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer: a randomized phase 3 trial" (2022, Nature Medicine)
  • "EZH2 inhibition activates a dsRNA-STING-interferon stress axis that potentiates response to PD-1 checkpoint blockade in prostate cancer" (2021, Nature Cancer)

Their frequent co-authors reflect an active collaboration network, including:

  • Silke Gillessen
  • Ian D. Davis
  • Anis Hamid
  • Nicholas D. James
  • Karim Fizazi

Christopher Sweeney's work integrates multiple aspects of cancer biology and treatment, with a clear focus on improving clinical understanding and therapeutic strategies for prostate and other related cancers. Their publication record and collaborative efforts indicate extensive involvement in ongoing cancer research and clinical trials within the medical community.

Best Publications

  • Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries.

    Claudia Allemani;Tomohiro Matsuda;Veronica Di Carlo;Rhea Harewood

  • Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer

    Christopher J. Sweeney;Yu Hui Chen;Michael Carducci;Glenn Liu

  • International incidence of childhood cancer, 2001-10 a population-based registry study

    Eva Steliarova-Foucher;Murielle Colombet;Lynn A G Ries;Florencia Moreno

  • Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer

    Ian D. Davis;Andrew J. Martin;Martin R. Stockler;Stephen Begbie

  • Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile

    Jeffrey Hrkach;Daniel Von Hoff;Mir Mukkaram Ali;Elizaveta Andrianova

  • Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED Trial

    Christos E. Kyriakopoulos;Yu Hui Chen;Michael A. Carducci;Glenn Liu

  • Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017

    Silke Gillessen;Gerhardt Attard;Tomasz M Beer;Himisha Beltran

  • Redefining the Target: Chemotherapeutics as Antiangiogenics

    Kathy D. Miller;Christopher J. Sweeney;George W. Sledge

  • An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cells

    Monica L. Guzman;Randall M. Rossi;Sundar Neelakantan;Xiaojie Li

  • Cabozantinib in Patients With Advanced Prostate Cancer: Results of a Phase II Randomized Discontinuation Trial

    David C. Smith;Matthew R. Smith;Christopher Sweeney;Aymen A. Elfiky

  • The antiangiogenic property of docetaxel is synergistic with a recombinant humanized monoclonal antibody against vascular endothelial growth factor or 2-methoxyestradiol but antagonized by endothelial growth factors.

    Christopher J. Sweeney;Kathy D. Miller;Sean E. Sissons;Shinichi Nozaki

  • Targeted therapy for advanced solid tumors on the basis of molecular profiles: Results from mypathway, an open-label, phase IIA multiple basket study

    John D. Hainsworth;Funda Meric-Bernstam;Charles Swanton;Herbert Hurwitz

  • Pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer (MyPathway): an updated report from a multicentre, open-label, phase 2a, multiple basket study.

    Funda Meric-Bernstam;Herbert Hurwitz;Kanwal Pratap Singh Raghav;Robert R McWilliams

  • Addition of docetaxel or bisphosphonates to standard of care in men with localised or metastatic, hormone-sensitive prostate cancer: a systematic review and meta-analyses of aggregate data

    Claire L. Vale;Sarah Burdett;Larysa H. M. Rydzewska;Laurence Albiges

  • Metastasis-Free Survival Is a Strong Surrogate of Overall Survival in Localized Prostate Cancer

    Wanling Xie;Meredith M. Regan;Marc Buyse;Susan Halabi

  • Enhancer RNAs participate in androgen receptor-driven looping that selectively enhances gene activation

    Chen-Lin Hsieh;Teng Fei;Yiwen Chen;Tiantian Li

  • Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015

    S Gillessen;A Omlin;G Attard;J S de Bono

  • Cyclooxygenase-2 expression in human pancreatic adenocarcinomas

    Michele T. Yip-Schneider;Darlene S. Barnard;Steven D. Billings;Liang Cheng

  • Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019[Formula presented]

    Silke Gillessen;Gerhardt Attard;Tomasz M. Beer;Himisha Beltran

  • The TMPRSS2:ERG Rearrangement, ERG Expression, and Prostate Cancer Outcomes: a Cohort Study and Meta-analysis

    Andreas Pettersson;Rebecca E. Graff;Scott R. Bauer;Michael J. Pitt

Frequent Co-Authors

Philip W. Kantoff
Philip W. Kantoff Memorial Sloan Kettering Cancer Center
Toni K. Choueiri
Toni K. Choueiri Harvard University
Paul L. Nguyen
Paul L. Nguyen Harvard Medical School
Quoc-Dien Trinh
Quoc-Dien Trinh Brigham and Women's Hospital
Mary-Ellen Taplin
Mary-Ellen Taplin Harvard University
Karim Fizazi
Karim Fizazi University of Paris-Saclay
Lorelei A. Mucci
Lorelei A. Mucci Harvard University
Michael A. Carducci
Michael A. Carducci Johns Hopkins University
Michael J. Morris
Michael J. Morris Memorial Sloan Kettering Cancer Center
Massimo Loda
Massimo Loda Cornell University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

While pursuing a medical degree in the USA is popular, many students explore alternative paths through online healthcare programs. These alternatives can offer greater flexibility and affordability, making them appealing to both new and returning learners.

One common concern is how much does online nursing school cost. Tuition varies widely depending on the institution, degree level, and study format, but many programs emphasize affordability to broaden access.

For those holding an RN credential, cheap rn to bsn programs offer a cost-effective path to advancing your nursing career. These bridge programs are popular among working professionals who want to qualify for specialized roles or leadership positions.

Ambitious nurses may consider earning an advanced degree through an online nursing doctorate. These programs prepare graduates for roles in research, education, and high-level administration.

If you did not major in nursing but wish to enter the field, there are now flexible options such as online direct entry msn programs for non-nursing majors. These programs enable a career switch by providing intensive, accelerated pathways into advanced nursing practice.

Best Scientists Citing Christopher Sweeney

Trending Scientists

Recently Published Articles